Drug
Hbs 301
Hbs 301: highest development phase Phase 3, developed by Harmony Biosciences Management, Inc.. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Harmony Biosciences Management, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| HBS-301 tablet NCT07500090 | Phase 3 | Idiopathic Hypersomnia |
| HBS-301 NCT07675135 | Phase 3 | EDS |
Latest
No recent events.
Follow Hbs 301 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.